Pub. Date : 2021
PMID : 33869031
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | In PDX models with mutated p53 status, there was significant tumor growth inhibition from the combination of AZD1775 with irinotecan or capecitabine (P <= 0.03), while PDX models with wild type p53 did not show anti-tumor synergy from the same combinations (P >= 0.08). | Irinotecan | tumor protein p53 | Homo sapiens |